Biocon has reported results for first quarter ended June 30, 2012.
The company has registered a rise of 13.97% in its net profit at Rs 68.84 crore for the quarter under review as compared to Rs 60.40 crore for the same quarter in the previous year. The total income from operation of the company has increased by 29.25% at Rs 469.27 crore for Q1FY13 as compared Rs 363.08 crore for the corresponding quarter previous year.
On the consolidated basis, the group’s net profit after taxes and minority interest surged by 12.49% to Rs 78.80 crore for the Q1FY13 as compared to Rs 70.05 crore in Q1 FY12. The total income rose 27.85% to Rs 592.60 crore in the quarter under review as compared to Rs 463.52 crore in the corresponding previous quarter.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1849.05 |
Dr. Reddys Lab | 1274.25 |
Cipla | 1553.20 |
Lupin | 2184.00 |
Zydus Lifesciences | 1001.85 |
View more.. |